Philadelphia’s Life Sciences momentum continues as Brandywine Realty Trust tenant, Jazz Pharmaceuticals, adds to their growing R&D portfolio with a $206.5 million acquisition
Philadelphia's cell & gene therapy momentum continues, thanks to top talent, strong investments, and future-focused institutions
Here’s What’s Next for Gene Therapy
Wrapping up BIO 2019, there are some key takeaways about the future of gene therapy in Philadelphia.
Philadelphia Shines in the Summer
There are a million reasons to #VisitPhilly.
Photos: Schuylkill Yards' new Drexel Square is officially open
"It's a little piece of heaven on a day like today," said Donna Henry, who was enjoying Drexel Square.
Developer Brandywine marks opening of park seen as first step toward big Schuylkill Yards project
Brandywine CEO Jerry Sweeney joined Philadelphia officials including Mayor Kenney to unveil the 1.3-acre Drexel Square park.
Spark CEO Marrazzo: Philadelphia will shine at BIO 2019
Jeff Marrazzo of Spark Therapeutics says Philadelphia can maximize our gene therapy momentum.
CSL Behring CEO: No better setting for BIO 2019 than Philadelphia
At BIO 2019, it’s all about scientific breakthroughs, innovative medicines, and helping patients overcome serious diseases.
As construction starts at Philly’s Schuylkill Yards, New York’s Hudson Yards serves as a cautionary tale
The future is here. Three buildings will be under construction at Schuylkill Yards by the year’s end.